These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24497006)

  • 1. Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date.
    Lee MR; Leggio L
    CNS Drugs; 2014 Feb; 28(2):107-19. PubMed ID: 24497006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy in alcoholism treatment: integrating and understanding the use of serotonin reuptake inhibitors.
    George FR
    Alcohol Alcohol Suppl; 1994; 2():537-43. PubMed ID: 8974380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
    Ray LA; Chin PF; Heydari A; Miotto K
    Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
    Rose AK; Jones A
    Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.
    Lynch WJ; Bond C; Breslin FJ; Johnson BA
    Psychopharmacology (Berl); 2011 Sep; 217(1):3-12. PubMed ID: 21424693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination pharmacotherapy for the treatment of neuropathic pain in adults.
    Chaparro LE; Wiffen PJ; Moore RA; Gilron I
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008943. PubMed ID: 22786518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
    Ait-Daoud N; Johnson BA; Prihoda TJ; Hargita ID
    Psychopharmacology (Berl); 2001 Feb; 154(1):23-7. PubMed ID: 11292002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.
    Stoops WW; Rush CR
    Expert Rev Clin Pharmacol; 2014 May; 7(3):363-74. PubMed ID: 24716825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid antagonists for alcohol dependence.
    Srisurapanont M; Jarusuraisin N
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining treatments for alcoholism: why and how?
    Mattson ME; Litten RZ
    J Stud Alcohol Suppl; 2005 Jul; (15):8-16; discussion 6-7. PubMed ID: 16223051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.
    COMBINE Study Research Group
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1107-22. PubMed ID: 12878917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review.
    Lev-Ran S; Balchand K; Lefebvre L; Araki KF; Le Foll B
    Can J Psychiatry; 2012 Jun; 57(6):342-9. PubMed ID: 22682571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
    Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
    J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence.
    Swift R; Pettinati HM
    J Stud Alcohol Suppl; 2005 Jul; (15):141-7; discussion 140. PubMed ID: 16223065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.
    COMBINE Study Research Group
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1123-31. PubMed ID: 12878918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.
    Garbutt JC; Kampov-Polevoy AB; Gallop R; Kalka-Juhl L; Flannery BA
    Alcohol Clin Exp Res; 2010 Nov; 34(11):1849-57. PubMed ID: 20662805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Trial of Combined tDCS Over Right Inferior Frontal Cortex and Cognitive Bias Modification: Null Effects on Drinking and Alcohol Approach Bias.
    Claus ED; Klimaj SD; Chavez R; Martinez AD; Clark VP
    Alcohol Clin Exp Res; 2019 Jul; 43(7):1591-1599. PubMed ID: 31081924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.